IGF-1 LR3 (Receptor Grade) is a synthetic peptide that belongs to the family of insulin-like growth factors (IGFs). It is a modified version of the naturally occurring hormone-insulin-like growth factor 1 (IGF-1). The “LR3” in its name refers to the long arginine 3 amino acid chain that has been added to increase its stability and half-life.
IGF-1 LR3 (Receptor Grade) is composed of 83 amino acids and has a molecular weight of approximately 9,200 Daltons. Its structure closely resembles that of natural IGF-1, but with the addition of the long arginine 3 chain. This modification allows for greater binding affinity to IGF receptors and prolongs its activity in the body.
IGF-1 LR3 (Receptor Grade) exhibits similar properties to endogenous IGF-1, including promoting cell growth, proliferation, and differentiation. However, due to its enhanced stability and extended half-life, it has become a popular choice for research purposes.
The main difference between IGF-1 and IGF-1 LR3 lies in their structure and function. While both compounds are involved in regulating cell growth and repair, IGF-1 LR3 has an extended half-life compared to natural IGF-1.
This means that it remains active in the body for a longer duration, allowing for sustained effects on cellular processes. Additionally, the long arginine 3 chain present in IGF-1 LR3 enhances its binding affinity to IGF receptors, leading to increased potency. This modification also makes it less susceptible to degradation by proteases, further contributing to its prolonged activity.
Overall, IGF-1 LR3 (Receptor Grade) offers distinct advantages over natural IGF-1 in terms of stability, half-life, and receptor binding affinity, making it a valuable tool for research purposes.
IGF-1 LR3 (Receptor Grade) is a modified version of insulin-like growth factor 1 (IGF-1), a naturally occurring hormone in the body. It works by binding to specific receptors on target cells, activating signaling pathways that promote cell growth and proliferation. When IGF-1 LR3 binds to its receptor, it triggers a cascade of events that lead to increased protein synthesis, DNA replication, and cell division.
This results in the growth and development of various tissues, including muscle, bone, and organs. One key feature of IGF-1 LR3 is its extended half-life compared to natural IGF-1. This is achieved through the addition of an amino acid sequence that protects it from degradation by enzymes in the body. The prolonged half-life allows for sustained activation of the receptor and prolonged effects on cellular processes.
Additionally, IGF-1 LR3 has been shown to have a higher affinity for its receptor compared to natural IGF-1. This means that it can bind more tightly and effectively activate the receptor, leading to enhanced biological activity.
Overall, IGF-1 LR3 works by stimulating cell growth and division through its interaction with specific receptors on target cells. Its extended half-life and increased receptor affinity make it a potent tool for promoting tissue growth and regeneration in research settings.
IGF-1 LR3 (Receptor Grade) offers several benefits in research applications due to its ability to promote tissue growth and regeneration. Some of the key benefits include:
1. Enhanced muscle growth: IGF-1 LR3 has been shown to stimulate muscle protein synthesis, leading to increased muscle mass and strength. This makes it valuable for studying muscle development and potential therapeutic applications in conditions such as muscle wasting.
2. Bone regeneration: IGF-1 LR3 has been found to promote bone formation and enhance the healing of fractures. It stimulates the proliferation and differentiation of osteoblasts, the cells responsible for bone synthesis. This makes it a promising candidate for studying bone regeneration and potential treatments for osteoporosis or bone injuries.
3. Improved recovery from injuries: IGF-1 LR3 has been shown to accelerate tissue repair and reduce recovery time in various injury models. It promotes the migration and proliferation of cells involved in wound healing, such as fibroblasts and endothelial cells. This makes it valuable for studying tissue repair mechanisms and potential therapies for wound healing disorders.
4. Neuroprotective effects: IGF-1 LR3 has demonstrated neuroprotective properties in preclinical studies. It promotes neuronal survival, enhances synaptic plasticity, and reduces inflammation in the brain. These findings suggest its potential use in studying neurodegenerative diseases or developing treatments for neurological disorders.
5. Anti-aging effects: Some research suggests that IGF-1 LR3 may have anti-aging effects by promoting cellular repair and regeneration processes. It has been shown to increase the lifespan of certain organisms and improve age-related decline in physiological functions.
Further research is needed to fully understand its mechanisms of action in aging processes. Overall, the benefits of IGF-1 LR3 make it a valuable tool for investigating tissue growth, regeneration, injury recovery, neuroprotection, and potential therapeutic interventions in various research areas.
While IGF-1 LR3 (Receptor Grade) offers numerous benefits in research applications, it is important to consider potential side effects that may arise from its use:
1. Hypoglycemia: IGF-1 LR3 can lower blood glucose levels by increasing glucose uptake in cells. This can potentially lead to hypoglycemia, especially if administered at high doses or in individuals with underlying blood sugar regulation issues. Monitoring blood glucose levels and adjusting dosage accordingly is important to prevent hypoglycemic episodes.
2. Organ enlargement: IGF-1 LR3 has the potential to promote organ growth, including the heart, liver, and kidneys. While this can be beneficial for studying tissue development, excessive organ enlargement may have negative consequences on organ function and overall health. Careful monitoring of dosage and duration of use is necessary to avoid unwanted organ hypertrophy.
3. Joint pain: Some users have reported experiencing joint pain as a side effect of IGF-1 LR3 use. This could be due to increased collagen synthesis and changes in connective tissue metabolism. Proper training techniques and joint support measures should be implemented during research involving IGF-1 LR3 to minimize the risk of joint discomfort.
4. Acromegaly: Prolonged and excessive use of IGF-1 LR3 can potentially lead to acromegaly, a condition characterized by abnormal growth of bones and tissues. This is more likely to occur when using high doses or for extended periods without proper monitoring. Regular assessment of growth parameters and discontinuation, if signs of acromegaly are observed, is crucial.
5. Other potential side effects: Additional side effects that have been reported include water retention, insulin resistance, changes in lipid profiles, and cardiovascular complications. These effects may vary depending on individual factors such as dosage, duration of use, and pre-existing health conditions. It is important to note that these side effects are primarily associated with improper or excessive use of IGF-1 LR3 in research settings.
IGF-1 LR3 (Receptor Grade) offers several advantages in research applications compared to other forms of IGF-1 or growth factors. Some of the key advantages include:
1. Extended half-life: IGF-1 LR3 has an extended half-life compared to natural IGF-1, allowing for sustained activation of its receptor and prolonged effects on cellular processes. This makes it a valuable tool for studying long-term tissue growth and regeneration.
2. Increased receptor affinity: IGF-1 LR3 has a higher affinity for its receptor compared to natural IGF-1, resulting in enhanced biological activity. This means that lower doses can be used to achieve desired effects, reducing the potential for side effects associated with higher dosages.
3. Enhanced stability: The modifications made to IGF-1 LR3 increase its stability and resistance to degradation by enzymes in the body. This allows for better control over dosage and ensures consistent results in research experiments.
4. Versatility: IGF-1 LR3 can be used in various research areas, including muscle development, bone regeneration, injury recovery, neuroprotection, and aging studies. Its ability to promote tissue growth and repair makes it a versatile tool for investigating different physiological processes.
5. Well-characterized product: Receptor Grade IGF-1 LR3 is produced under strict quality control measures and undergoes rigorous testing to ensure purity and potency.
This provides researchers with confidence in the reliability and reproducibility of their experiments. Overall, the advantages of using IGF-1 LR3 (Receptor Grade) make it a preferred choice for researchers studying tissue growth, regeneration, and related processes. (Continued below)
IGF-1 LR3 (Receptor Grade) is a peptide that has gained significant attention in the field of research due to its potential applications and benefits. There are several research topics related to IGF-1 LR3 that scientists are exploring:
One of the primary areas of research is focused on understanding the role of IGF-1 LR3 in promoting muscle growth. Studies have shown that this peptide can enhance muscle hypertrophy by increasing protein synthesis and inhibiting protein breakdown. Researchers are investigating the underlying mechanisms and potential therapeutic applications for conditions such as muscle-wasting diseases.
USD
EUR
GBP
CAD